Back to Journals » Research and Reviews in Parkinsonism » Volume 2

Effects of deep brain stimulation amplitude on motor performance in Parkinson’s disease

Authors Conovaloff A, Krishnamurthi, Mahant, Samanta, Abbas

Received 18 September 2012

Accepted for publication 24 October 2012

Published 11 December 2012 Volume 2012:2 Pages 73—83


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Alison Conovaloff,1 Narayanan Krishnamurthi,1 Padma Mahant,2 Johan Samanta,2 James Abbas1

1Center for Adaptive Neural Systems, School of Biological and Health Systems Engineering, Ira A Fulton School of Engineering, Arizona State University, Tempe, AZ, USA, 2Movement Disorders Clinic, Banner Good Samaritan Medical Center, Phoenix, AZ, USA

Background: The efficacy of deep brain stimulation (DBS) in Parkinson’s disease has been convincingly demonstrated in studies comparing motor performance with and without stimulation, but characterization of the stimulation dose-response curves has been limited.
Methods: In a series of case studies, eight subjects with Parkinson’s disease and bilateral DBS systems were evaluated at their clinically determined stimulation (CDS) and at three reduced amplitudes, ie, approximately 70%, 30%, and 0% of the CDS (MOD, LOW, and OFF, respectively). Performance was assessed using the motor section of the Unified Parkinson’s Disease Rating Scale (UPDRS-III), which includes subscores for tremor, bradykinesia, gait, posture, and tapping. Data at the reduced settings were analyzed to determine if individual subjects demonstrated a threshold-like response, which was defined as a dose-response curve in which one decrement in stimulation accounted for ≥70% of the maximum change observed. Day-to-day variability was assessed using the CDS data from the three different days.
Results: In the dose-response curves, two subjects exhibited a threshold-like response, four exhibited a graded change, and two did not exhibit substantial changes. For some subjects, variability in CDS performance across the three days exceeded the change observed when reducing amplitude to the MOD setting. Comparisons across this set of eight subjects demonstrated that the mean UPDRS-III and all but one subscore significantly increased (performance degraded) when amplitude was reduced from CDS to the LOW and OFF conditions, but there were no significant changes when amplitude was reduced from CDS to the MOD condition.
Conclusion: Individual differences in the DBS dose-response curves may provide opportunities to optimize clinical performance. Day-to-day variability in motor performance cautions against the use of a single UPDRS measurement in clinical selection of DBS settings.

Keywords: deep brain stimulation, Parkinson’s disease, Unified Parkinson’s disease rating scale, motor performance

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]